Lakewood-Amedex Biotherapeutics, Inc. (LABT)

NASDAQ: LABT · Real-Time Price · USD

0.2015

-0.0358 (-15.09%)

Oct 30, 2026, 3:31 PM EDT - Market open

LABT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.02	-0.84	0.67	0.13
Net Debt / Equity Ratio	-1.03	-0.72	-1.00	-1.27
Net Debt / EBITDA Ratio	0.62	-0.38	0.10	0.67
Net Debt / FCF Ratio	1.29	-0.73	0.07	0.85
Quick Ratio	7.29	0.10	1.36	3.10
Current Ratio	7.70	0.13	1.55	3.14
Return on Equity (ROE)	-402.83%	-	-195.47%	-
Return on Assets (ROA)	-139.40%	-303.80%	-63.20%	-
Return on Capital Employed (ROCE)	-167.80%	196.10%	-706.50%	-178.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-27.02%	-0.78%	-1.44%	-

SEC Filings: 10-K · 10-Q